SLDB - Solid Bio Qarzning balans kapitallashuviga nisbati

Solid Bio (SLDB) kompaniyasining korporativ logotipi

Solid Biosciences Inc. (SLDB) uchun quyidagi kotirovkalar virusli vektorlar ishlab chiqarishni tashqi pudratchilar orqali to'liq autsorsing qilish modeliga asoslangan kompaniyaning faoliyatini aks ettiradi. Dori vositalarini tashish paytida harorat nazoratiga qat'iy rioya qilish bu yerda muhim bo'g'in vazifasini o'taydi. Bundan tashqari, biznes barqaror geosiyosiy fondga tayanadi, chunki dori vositalarining gumanitar maqomi tashqi xavflarni minimallashtiradi va ko'rsatkich 0.05 darajasida turibdi.

Solid Biosciences Inc. (SLDB) - Balans qiymatiga qarzlar 04.07.2022dan 27.10.2026gacha

Solid Biosciences Inc (SLDB) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Solid Biosciences Inc.|SLDB - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Solid Corp|SLDB - Kompaniyani sotib olish narxi
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Solid Biosciences|SLDB - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati solidbio.com|SLDB - Kompaniyaning jami aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Solid Biosciences Inc.|SLDB - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Solid Bio|SLDB - Kompaniyaning jamlangan qarzi|Qarzning balans qiymatiga nisbati Solid Corp
Kompaniyaning barcha koʻrsatkichlari tahlili:SLDB, Solid Biosciences Inc.
Solid Biosciences Inc brendining mahsuloti

Ushbu koeffitsiyent umumiy kapital tuzilmasidagi qarz mablag‘larining ulushini o‘lchaydi, bu esa investorlarga moliyaviy leveraj darajasi va bankrotlik xavfini baholash imkonini beradi. GURU.Markets platformasida kompaniyaning umumiy qarzi va kapitalning balans qiymati nisbatini tahlil qilish orqali, Duchenne gen terapiyasi rivojlantirish strategiyasi joriy likvidlik rezervlarini saqlagan holda ulkan R&D xarajatlarini talab qiladigan Solid Biosciences Inc. (SLDB) barqarorligini tasdiqlash mumkin.

Solid Biosciences Inc. raqobatchilari

Balans kapitallashuviga qarzlar TEM (Tempus AI Inc)|qiagen.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati IONS (Ionis)|RGEN: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati RNA|CRSP (CRISPR) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati GeneDx Holdings Corp.|Qarzning balans kapitallashuviga nisbati ultragenyx.com|BEAM (Beam Therapeutics) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar Sarepta Therapeutics (SRPT)|TWST - Balans kapitallashuviga qarzlar|TXG - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati Intellia Therapeutics (NTLA)|STOK - Qarzning sof aktivlarga nisbati|BioLife Solutions (BLFS) - Balans kapitallashuviga qarzlar|Wave Life Sciences Ltd (WVE) - Qarzning balans kapitallashuviga nisbati|MAZE: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar SION|Prime Medicine, Inc. - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar TSHA (tayshagtx.com)|Qarzning balans kapitallashuviga nisbati QURE|Sof aktivlarga qarzlar MeiraGTx Holdings MGTX|RGNX: Balans kapitallashuviga qarzlar|OCGN - Qarzning balans qiymatiga nisbati|Pacific Biosciences - Balans kapitallashuviga qarzlar|benitec.com (BNTC) - Sof aktivlarga qarzlar|Balans kapitallashuviga qarzlar DSGN (Design Therapeutics, Inc.)|Balans qiymatiga qarzlar RCKT|Qarzning balans kapitallashuviga nisbati 4D Molecular Therapeutics Inc FDMT|Qarzning balans qiymatiga nisbati lexeotx.com (LXEO)|Korro Bio - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati editasmedicine.com EDIT|SLN (Silence Therapeutics plc) - Balans kapitallashuviga qarzlar|PRQR: Balans qiymatiga qarzlar|codexis.com - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Sangamo BioSciences|NAUT - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati metagenomi.co|DTIL (Precision BioSciences, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar GBIO (generationbio.com)|BOLD - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Exicure Inc. XCUR|IMNN: Balans kapitallashuviga qarzlar|Phio Pharmaceuticals (PHIO) - Qarzning balans qiymatiga nisbati|mustangbio.com - Qarzning balans qiymatiga nisbati|RNAZ (TransCode Therapeutics, Inc.) - Sof aktivlarga qarzlar|BNGO: Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar APDN|Qarzning balans kapitallashuviga nisbati bluebird bio, Inc. (BLUE)|Qarzning balans kapitallashuviga nisbati immunoprecise.com (IPA)|OMGA - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Singular Genomics Systems, Inc. OMIC|RGLS - Balans kapitallashuviga qarzlar|SYRS - Qarzning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar Telesis Bio, Inc.|TCON (traconpharma.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati Unity Biotechnology, Inc. (UBX)